World Health Organization site
Skip Navigation Links
Advanced Search
List ByExpand List By
Search Tips
ICTRP websiteExpand ICTRP website
Contact us
                   4571 records for 1160 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusMain ID Public TitleDate of Registration
A Clinical Study to Compare the effectiveness and safety of Lefamulin (BC 3781) Versus Moxifloxacin (With or Without added Linezolid) in Adults With Community-Acquired Bacterial Pneumonia
Not recruitingNCT02596230
RE-COVERY DVT/PE: Global Study on Treatment Secondary Prevention of Acute Venous Thromboembolism
Screening Day Latin America
Not recruitingNCT02573350
A Phase 2, Multi-center, Uncontrolled, Open-label Trial to Evaluate Safety, Tolerability, and Efficacy of Orally Administered OPC-67683
Not recruitingNCT02563054
A Study of Capecitabine (Xeloda) in Participants With Advanced or Metastatic Gastric Cancer
Pulsatile, audible, tactile stimulation for premature babies in neonatal intensive care units to reduce pain and increase weight gain
This study will be researching a specific substance in your blood called interferon alpha (IFNa). You have lupus and as a result have high amounts of IFNa. This means that the body’s natural defense system (immune system) attacks healthy tissues instead of attacking only things like bacteria and viruses.
Recruitment statusMain IDPublic titleDate of registration
AuthorisedEUCTR2015-001341-86-HRPhase IIb study of IFN-K in Systemic Lupus Erythematosus10/11/2015
Not recruitingNCT02547922
Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis
A Randomized, Multicenter, Double-Blind, Phase 3 Study of Nivolumab, Nivolumab in Combination With Ipilimumab, or Placebo as Maintenance Therapy in Subjects With Extensive-Stage Disease Small Cell Lung Cancer (ED-SCLC) After Completion of Platinum-based First Line Chemotherapy
A Multi-Site, Open-Label Extension Trial of Oral RPC1063 in Relapsing Multiple Sclerosis
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.2 - Version history